Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Adrenergic Receptors: ɑ Subtype

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...

Adrenergic Receptors: β Subtype

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Neoceptor concept based on molecular complementarity in GPCRs: a mutant adenosine A(3) receptor with selectively enhanced affinity for amine-modified nucleosides.

Journal of medicinal chemistry·2001

Same author

A novel contractile phenotype with cardiac transgenic expression of the human P2X4 receptor.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2001

Same author

A novel cardioprotective role of RhoA: new signaling mechanism for adenosine.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2001

Same author

P2 purinergic receptor activation enhances cardiac contractility in isolated rat and mouse hearts.

American journal of physiology. Heart and circulatory physiology·2001

Same author

Constitutive activation of A(3) adenosine receptors by site-directed mutagenesis.

Biochemical and biophysical research communications·2001

Same author

Protection of cardiac myocytes via delta(1)-opioid receptors, protein kinase C, and mitochondrial K(ATP) channels.

American journal of physiology. Heart and circulatory physiology·2000

Same journal

Comment on "Advancing Personalised Care in Atrial Fibrillation and Stroke: The Potential Impact of AI from Prevention to Rehabilitation".

Trends in cardiovascular medicine·2026

Same journal

Response to: Comment on "Advancing personalised care in atrial fibrillation and stroke: The potential impact of AI from prevention to rehabilitation" (TCM-D-26-00198).

Trends in cardiovascular medicine·2026

Same journal

High-sensitivity C-reactive protein as a prognostic biomarker in cardiovascular diseases: implications for atherosclerosis, chronic kidney disease, and heart failure - a review.

Trends in cardiovascular medicine·2026

Same journal

The cost of false dichotomies in a dynamic disease.

Trends in cardiovascular medicine·2026

Same journal

Late-presenting ST-segment elevation myocardial infarction: is it just a matter of time? From temporal cutoffs to biological staging.

Trends in cardiovascular medicine·2026

Same journal

Targeting rotors in ventricular fibrillation: Molecular mechanisms and future therapeutic strategies.

Trends in cardiovascular medicine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 5, 2026

Use of a Hanging Weight System for Coronary Artery Occlusion in Mice

Use of a Hanging Weight System for Coronary Artery Occlusion in Mice

Published on: April 19, 2011

Adenosine receptors and cardiovascular function.

¹Department of Medicine, Cardiology Division, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.

Trends in Cardiovascular Medicine

|January 18, 2011

Summary

This summary is machine-generated.

Adenosine significantly impacts heart and blood vessel function through distinct A(1) and A(2) receptors. Understanding these adenosine receptors at a molecular level is key to advancing cardiovascular medicine.

More Related Videos

Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System

Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System

Published on: May 22, 2018

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

Related Experiment Videos

Last Updated: Jun 5, 2026

Use of a Hanging Weight System for Coronary Artery Occlusion in Mice

Use of a Hanging Weight System for Coronary Artery Occlusion in Mice

Published on: April 19, 2011

Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System

Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System

Published on: May 22, 2018

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

Area of Science:

Cardiovascular Pharmacology
Molecular Biology
Receptor Physiology

Background:

Adenosine significantly influences cardiac and vascular systems.
Specific adenosine receptors are located on endothelial cells and myocytes.
These receptors mediate diverse cardiovascular effects.

Purpose of the Study:

To explore the cardiovascular effects of adenosine.
To elucidate the roles of distinct adenosine receptor subtypes (A(1) and A(2)).
To understand the molecular mechanisms underlying adenosine's actions.

Main Methods:

Investigated the coupling of A(1) and A(2) adenosine receptors to G proteins and second messengers.
Utilized recent advancements in adenosine receptor cloning.
Examined the structure, function, and regulation of adenosine receptors.

Main Results:

Identified distinct cardiovascular effects mediated by different adenosine receptor subtypes.
Characterized the differential coupling of A(1) and A(2) receptors to specific signaling pathways.
Highlighted the potential for discovering novel, tissue-specific adenosine receptor subtypes.

Conclusions:

Molecular cloning of adenosine receptors enhances understanding of their structure and function.
These advances offer insights into adenosine's cardiovascular mechanisms.
Adenosine's clinical utility in cardiovascular medicine is expanding.